0001104659-22-000473.txt : 20220103 0001104659-22-000473.hdr.sgml : 20220103 20220103171645 ACCESSION NUMBER: 0001104659-22-000473 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220103 DATE AS OF CHANGE: 20220103 EFFECTIVENESS DATE: 20220103 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Petros Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001815903 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 851410058 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-427696 FILM NUMBER: 22503080 BUSINESS ADDRESS: STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 973-242-0005 MAIL ADDRESS: STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 D 1 primary_doc.xml X0708 D LIVE 0001815903 Petros Pharmaceuticals, Inc. 1185 AVENUE OF THE AMERICAS, SUITE 249 NEW YORK NY NEW YORK 10036 973-242-0005 DELAWARE None None Corporation true 2020 Mitchell Arnold 1185 Avenue of the Americas, Suite 249 New York NY NEW YORK 10036 Executive Officer Vice President of Finance and Principal Accounting Officer Fady Boctor 1185 Avenue of the Americas, Suite 249 New York NY NEW YORK 10036 Executive Officer President and Chief Commercial Officer John D. Shulman 1185 Avenue of the Americas, Suite 249 New York NY NEW YORK 10036 Director Joshua N. Silverman 1185 Avenue of the Americas, Suite 249 New York NY NEW YORK 10036 Director Bruce T. Bernstein 1185 Avenue of the Americas, Suite 249 New York NY NEW YORK 10036 Director Gregory Bradley 1185 Avenue of the Americas, Suite 249 New York NY NEW YORK 10036 Director Wayne R. Walker 1185 Avenue of the Americas, Suite 249 New York NY NEW YORK 10036 Director Andrew Gesek 1185 Avenue of the Americas, Suite 249 New York NY NEW YORK 10036 Executive Officer President, Timm Medical Pharmaceuticals Decline to Disclose 06b false 2021-12-22 false true true true false 0 8324820 2200023 6124797 641406 shares of common stock at $3.43/sh, warrants to purchase up to 1639942 shares of common stock at $3.50/sh, & warrants to purchase up to 110000 shares of common stock at $3.50/sh issued to financial advisor in connection w/ offerings closed 12/27/21 false 12 0 0 0 false Petros Pharmaceuticals, Inc. /s/ Mitchell Arnold Mitchell Arnold Vice President of Finance and Principal Accounting Officer 2022-01-03